US Stock MarketDetailed Quotes

CARA Cara Therapeutics

Watchlist
  • 0.351
  • +0.008+2.33%
Close Aug 8 16:00 ET
19.19MMarket Cap-155P/E (TTM)

Cara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cara Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 13, 2024

Revenue(YoY)

2.13M

-65.37%
EPS(YoY)

-0.56

-14.29%
Analyst Rating

Hold

Aug 8, 2024

Cara Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.750M--
--2024/Q2-- / 1.174M--
May 13, 20242024/Q12.135M / 1.690M--
Mar 4, 20242023/Q43.004M / 9.135M--
Nov 13, 20232023/Q34.866M / 11.101M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.750M--
--2024/Q2-- / 1.174M--
May 13, 20242024/Q12.135M / 1.690M--
Mar 4, 20242023/Q43.004M / 9.135M--
Nov 13, 20232023/Q34.866M / 11.101M--

Unlock Free Earnings Estimates

Cara Therapeutics Earnings Reports

  • Cara Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 13 16:20 ET

  • Cara Therapeutics | 10-K: FY2023 Annual Report

    Mar 6 16:22 ET

  • Cara Therapeutics: Q3 2023 Earnings Report

    Nov 13, 2023 16:20 ET

  • Cara Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 7, 2023 16:16 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 8, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg